Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia
National Cancer Institute (NCI)
Atara Biotherapeutics
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Baylor College of Medicine
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
University of Rochester
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center